D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol (Berl), vol.131, issue.6, pp.803-823, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-96, 2005.

R. Stupp, M. E. Hegi, W. P. Mason, M. J. Van-den-bent, M. Taphoorn et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, issue.5, pp.459-66, 2009.

M. E. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, vol.352, issue.10, pp.997-1003, 2005.

J. R. Perry, N. Laperriere, C. J. O'callaghan, A. A. Brandes, J. Menten et al., ShortCourse Radiation plus Temozolomide in Elderly Patients with Glioblastoma, N Engl J Med, vol.376, issue.11, pp.1027-1064, 2017.

R. Stupp, S. Taillibert, A. A. Kanner, S. Kesari, D. M. Steinberg et al., Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial, JAMA, vol.314, issue.23, pp.2535-2578, 2015.

O. L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma, N Engl J Med, vol.370, issue.8, pp.709-731, 2014.

W. Wick, T. Gorlia, M. Bendszus, M. Taphoorn, F. Sahm et al., Lomustine and Bevacizumab in Progressive Glioblastoma, N Engl J Med, vol.377, issue.20, pp.1954-63, 2017.

M. J. Van-den-bent, A. A. Brandes, M. Taphoorn, J. M. Kros, M. Kouwenhoven et al., Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951, J Clin Oncol Off J Am Soc Clin Oncol, vol.31, issue.3, pp.344-50, 2013.

J. G. Cairncross, M. Wang, R. B. Jenkins, E. G. Shaw, C. Giannini et al., Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH, J Clin Oncol, vol.32, issue.8, pp.783-90, 2014.

J. C. Buckner, E. G. Shaw, S. L. Pugh, A. Chakravarti, M. R. Gilbert et al., Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma, N Engl J Med, vol.374, issue.14, pp.1344-55, 2016.

, / Maladies chroniques et traumatismes / Rapports et synthèses / Publications et outils / Accueil [Internet, 1989.

, Glioblastoma survival: has it improved? Evidence from population-based studies

, Antiangiogenic therapy for high-grade glioma, 2015.

, Descriptive epidemiology of cerebral gliomas in France. -PubMed -NCBI, 2016.

, Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain), vol.16

T. B. Johannesen, E. Angell-andersen, S. Tretli, F. Langmark, and K. Lote, Trends in Incidence of Brain and Central Nervous System Tumors in Norway, Neuroepidemiology, vol.23, issue.3, pp.101-110, 1970.

T. A. Dolecek, J. M. Propp, N. E. Stroup, and C. Kruchko, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009. Neuro-Oncol, vol.14, pp.1-49, 2012.

, Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical pr

, 20. classification internationale des maladies pour l'oncologie cim o 3 -Recherche Google, 2015.

, The 2007 WHO Classification of Tumours of the Central Nervous System, 2015.

L. Insee--département-de and . Somme, Dossier complet, vol.80, 2016.

, Enregistrement des Cancer : Principes et Méthodes, 2016.

, Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period, 2000.

, Association between brain tumors and menopausal status, 2016.

F. Ménégoz, E. Martin, A. Danzon, H. Mathieu-daudé, A. Guizard et al., Incidence and mortality of central nervous system tumors in France: trends over the period 1978-2000 and influence of registration practices on results, Rev Epidémiologie Santé Publique, vol.54, issue.5, pp.399-406, 2006.

, ANOCEF -Association des Neuro-Oncologue d'Expression Française, 2016.

, Annexe 2: Article soumis à la revue « Journal of Cancer Policy